ACC 2023 Conference Coverage


 

ACC 2023: Evaluation of the Mechanism of Benefit for Dapagliflozin in HFpEF - An Invasive Hemodynamic Randomized Trial

1,317 views
March 15, 2023
3 Comments
Login to view comments. Click here to Login
Videos